期刊文献+

生物活性PCL/PLA三维多孔块膜为载体的骺软骨细胞体外实验研究 被引量:4

The Experimental Study of the 3D and Porous Activable Biodegradative and Absorbale Materials for Epiphyseal Plate Tissue Engineering in Vitro
下载PDF
导出
摘要 目的 探讨以生物活性聚己内酯 /聚乳酸共聚物 (PCLPLA)为载体的兔骺软骨细胞体外培养的可行性。方法 应用具有三维多孔立体结构的生物活性支架材料 (PCLPLA)为细胞外基质替代物 ,体外进行兔骺软骨细胞培养。采用组织学、电镜、MTT比色法、免疫组化法等多种手段动态检测细胞生长情况。结果 兔骺软骨细胞生长良好 ,增殖活跃 ,合成大量软骨基质 ,并与材料形成细胞———材料复合体 ,细胞充满于材料孔隙内。结论 生物活性可降解吸收材料PCLPLA具有良好的组织相容性及表面活性 ,它所提供的三维立体空间结构有利于细胞生长繁殖。为探讨骨骺早闭的全新疗法奠定了基础。 Objective To discuss the possibility of taking the new biodegradative and absorbable materials PCL/PLA as the carrier to cultivate epiphyseal plate cells in vitro in order to lay a foundation for the new method of treatment of growth arrest.Methods Carrying on the culture of epiphyseal plate cells in vitro by applying 3D and porous activable PCL/PLA as scaffolds,which are inside the body of organism and can be degraded and absorbed.Checking up the conditions of the growth of the cells by applying the ways of histology,electron microscope,MTT test and immunohistochemistry.Results The cells of epiphyseal plate grow well,increase actively,synthetize cartilage matrix and produce cells by combining the materials-cells compound,which the hole of the materials being full cells.Conclusion The newly biodegradative and absorbable materials PCL/PLA has the characters of better histocompatibility and surface activity.The 3D construction of that is propitious to the growth of the cells.The test lays a foundation for the new method of the treatment of growth arrest.
出处 《骨与关节损伤杂志》 2001年第5期355-358,I002,共5页 The Journal of Bone and Joint Injury
基金 国家自然科学基金资助项目 (编号 :3980 0 1 51 )
关键词 组织工程 生物降解活性材料 骺软骨细胞 骨形态发生蛋白 实验研究 Tissue engineering Biodegradative activable materials Cells of epiphyseal plate BMP
  • 相关文献

参考文献5

二级参考文献2

  • 1Cao Y L,Plast Reconstr Surg,1997年,100卷,297页
  • 2Langer R,Science,1993年,260卷,920页

共引文献50

同被引文献25

  • 1Baltzer AWA, Lattermann C, Whalen JD, et al. Genetic enhancement of fracture repair: healing of an experimental segmental defect by adenoviral transfer of the BMP - 2 gene. Gene Therapy, 2000,7:734.
  • 2Lieberman JR, Daluiski A, Stevenson S, et al. The effect of regional gene therapy with bone morphogenetic protein - 2 - producing bone- marrow cells on the repair of segmental femoral defects in rats.J Bone Joint Surg (Am), 1999, 81 (7): 905.
  • 3Bellincampi LD, Closkey RF, Prasad R, et al. Viability of fibrob-last - seeded ligament analogs after autogenous implantation. J Orthop Res, 1998, 16 (4): 414.
  • 4Ebara S, Nakayama K. Mechanism for the action of bone morphogenetic proteins and regulation of their activity. Spine, 2002, 27 :10.
  • 5Alden TD, Pittman DD, Hankins GR, et al. In vivo endochondral bone formation using a bone morpbogenetic protein 2 adenoviral vector. Hum Gene Ther, 1999, 10 (13): 2245.
  • 6Tsuchida H, Hashimoto J, Crawford E, et al. Engineered allogeneic mesenchymal stem ceils repair femoral segmental defect in rats. J Orthop Res, 2003, 21 (1): 44.
  • 7Laurencin CT, Attawia MA, Lu LQ, et al. Poly (lactide- coglycolide) /hydroxyapatite delivery of BMP - 2 - producing cells: a regional gene therapy approach to bone regeneration. Biomaterials,2001, 22 (11): 1271.
  • 8Rutherford RB, Moalli M, Franceschi RT, et al. Bone morphogenetic protein - transduced human fibroblasts convert to osteoblasts and form bone in vivo. Tissue Engineering, 2002, 8:441.
  • 9Middleton JC, Tipton AJ. Synthetic biodegradable polymers as orthopedic devices[J]. Biomaterials, 2000, 21: 2335 - 2346.
  • 10Bostman O, Pihlajamaki H. Clinical biocompatibility of biodegeneradable orthopaedic implants for internal fixation: a review[J]. Biomaterials, 2000, 21:2615- 2621.

引证文献4

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部